A B S T R A C T The effect of 8 mg/kg of indomethacin on uterine blood flow, prostaglandin prodtuction, and intraamniotic fluid pressuire was examined in late pregnant dogs. Uterine blood flow was measured with 15 gm radiolabeled microspheres. Becauise we f0)und that a significant percentage of the microspheres shunted through the placental circulation into the lungs, we calcuilated placental blood flow by adding the shunted microspheres through the placenta to the nonshunited microspheres in the placenta. Total uterine blood flow significantly increased from 271±69 ml/min during control period to 371±72 ml/min (P < 0.01) 30 min af ter indomethacin. This increase was attributable to the change in blood flow to the placental circulation (222 ±58 to 325±63 ml/min; P < 0.01). Associated with these hemodynamic changes we f0und an almost complete suppression of uterine prostaglandin E2 prodtuction (1,654±305 to 51±25 pg/ml; P < 0.01) as meastired by gas chromatography-mass spectrometry. In addition, we found that indomethacin treatment restulted in uterine relaxation as measured by intraamniotic fluiid pressure changes (11.2± 1.3 mm Hg to 8.5 +1.2 mm Hg; P < 0.001).
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We conclude that indomethacin causes an inerease in placental blood flow without any change in flow to the rest of the uterus, and that this dose of' the drug inhibits greater than 95% of uterine prostaglandin production. In addition, indomethacini is responsible for uterine relaxation. The increase in placental blood flow after indomethacin is probably a result of uterine relaxation, which is secondary to prostaglandin synthesis inhibition.
INTRODUCTION
During pregnancy and parturition there are chan-ges in the prostaglandin systemii that have suggested a potential physiological role for these fatty acids; however, their exact role is undefine(l. With rhestus monkeys, Novy et al. showed that indomethacini, anl inhibitor of' prostaglandin synthesis, blocked the normal onset of parturition (1) . Zuckerman et al. later reported that indomethacin was sucecessful in arresting premature labor in women whose cervix vas less thani 3 cm dilated and produced minimal side effects to the mother and fetus (2 (6, 7) . The spiral arteries feed directly into the intervillous spaces wvhere maternal and fetal exchange of nutrients occurs. Spiral arteries histologically show musculoelastic degeneration mnost pronounced in the endometrium buit also present in the myometritum (8 (16) .
The intervillous space of the placenta off'ers very little resistaince to the 15-,um microspheres; thus, w.e found that most ofthe spheres pass through the placental circulation and lodge in the lungs. We devised a method to measure placental blood flow taking advantage of' the shunt. Assuminig the shunt is entirely through the placenta, the placental blood flow can be calculated by determining the extrauterine, arterial-venous shutnt in each dog after complete initerruption of the uteroplacental cireculationi (period 3) and by the following formula:
placental blood flow = PR + (TLR -ELR) x cardiac outplt. PR = placental radioactivity; TLR = total lung radioactivity with uiteroplacental circulation intact; ELR = fraction of radioactivity in the lutngs that is extrauterine. The extraplaceiotal uiterine blood flowvs was caleulated from the fraction of radioactivity in the rest of the utertus mulltiplied by the cardiac olutplt.
Intraanmiotic fluid pressure flleastiremt71ents. Fouir late pregnanit clogs were anesthetized with pentobarbital 30 mig/ kg, intubated, and ventilated withl a positive pressure respiiator. The femoral artery and vein were cannulated for continuious blood pressuire monitoring and druig admIlinistration.
Through a midline low-abdominal incisio 0 the pregnant uiterus was exposed and one fettus identified. A catheter xwas passed into the anmniotic sac unitil there was f'ree flow of amniotic fluid; catheter vas then attached to a pressture transdticer to monitor amiiniotic fluiid pressture. The abdomen was closed, and the animllal was allowed to stabilize. The experiment consisted of' an initial control periodl of' 2 h followed by the adminiistrationi of' 8 mg/kg of' indomiiethacini intravenously wvith continuious recordling of'the intraamniotic fllid presstires.
Prostaglanrdiui analt sis. In the six pregnant clogs f'rom the hemodvnamic stuidies, 12-15 ml of' 1)loo( was drawn f'roim the aorta and uiterine vein into plastic syringes containing 0.1 vol of'3.8% sodiium citrate and 1% indlometlhacin dulrinig the control period, and 30 min after 8 mng/kg of indomethacill.
The blood wvas immediately transf'erred to a glass centrifulge tube, cooled to 0-5°C, and the plasma isolated by cenitrif'igation at 8,000 g for 15-20 min. The plasma voltime and lemlatocrit were recorded and the plasma transferred to a 100-mIl centrifulge tube. Internal standards and radioactive tracers wvere addecl to the plasma before f'reezing at -20(C. The internal stanidardIs employed were 3,3,4,4-tetradeutero-analogues of' PGE2' (prostaglandin E2, 1,500 ng) ancl 1.5 keto-13,14-dihydro (15 KH2) PGE2 (1,200 ng) (generotus gifts of'the Upjohln Co., Kalamazoo, Mich. Dr. U. Axen). Approximately 150,00() dpm of' each of the tritiated analogtues (120,000(-170,000 mCi/mmnol, Amersham Corps., Arlington Heights, 111.) were added as tracers to f:acilitate isolation and pulrification of' the prostaglandinis.
The prostaglandins vere extracted into chloroform in acid pH (pfH 3.0) and the methyl esters formed with diazomethane. Initial pturification and chromatographic separation of PGE2-methyl ester and 1 5-keto-13,14-clihy(lro PGE2-methyl ester were achieved via high perf'ormance li(qticl chromatographv as described by Hubbard and Watson (17) . Final puirification aind (qtuantificationi of' PGE2 and 15 KH2E2 was achievedl via combined gas chromatography-mass spectrometry with selected ion monitoring. Before gas chromatography-mass spectrometrv analysis, PGE2-methyl ester was converted to the 0-metlhoxime-bis-acetate derivative. 15 KH2E2-methyl ester was converted to the bis-0-mnethoxime-trimethylsilyl ether clerivative. Gas chromatography-mass spectrometry analysis of the derivatizecl PGE2 and 15 KH2E2 wvas accomiiplished on a IHewlett-Packard model 5982A gas chromatograph-mass spec- 2350C was employed. The ion pair for selective ion monitoring analysis of the derivatized PGE2 and its internal standard was mass/charge 419 and 423. The ion pair for selective ion moniitoring analysis of the derivatized 15 KH2E2 and its internal standard was mnass/charge 375 antd 379. The (letectioni limits of these assays are 100 pg/ini for PGE2 anid 50 pg/miil for 15 KH2E2. The net prostaglanidiin levels were calculated by suibstractinig arterial from venous blood levels.
Statistics. Data were analyzed with Sttudenit's t test for paired comparisons, comparing control restults to the results 30 min after 8 mg/kg of indomethacin.
RESULTS
In the six dogs studied, 30 miim after indomethacini the total blood flow to the uterus increased significanitly from a mean of 271+69 to a mean of 371±72 ml/min (Table 1) . Even though the arterial pressure increased after indomethacin, the uteroplacental vascular resistance significantly decreased indicating vasodilation. There was also no significant change in cardiac output to explain changes in flow (Table I ). The increase in uteroplacental blood flow was entirely diie to the significant increase in placental blood flow, as the flow to the remainder of the uiteruis showed no consistenit change after 8 nmg/kg of in-domethacin (Fig. 1) . Placental blood flowv accotunted for 81 % of the total uiterine blood flow which is in agreement with the literature (18) .
Uterine blood flow represented 14.2% ofthe total cardiac output which is also in agreemienit with the literatuire (19, 20) . Becauise the present methodology for measuiring uterine blood flow is novel, we me-asured the right uterine arterial blood flow electromagnetically (Stathamii Instruments, Inc., Oxnard, Calif.) in two addlitional pregnant mongrel dogs. In both dogs indometlhaci inicreased the right uterinie arterial blood flow wvitlhin 30 The sensitivity of our assay was 50 pg/ml. Because various nonsteroidal, anti-inflammatory drugs have been reported to be associated with uterine relaxation (10-12, 14, 15) , we looked at the effect of indomethacin in this regard. Before indomethacin the amniotic fluid pressure showed small rhythmic variations, but the mean pressure remained constant during the 2-h control period. After indomethacin the amniotic fluid pressure decreased over 30 min and lost its rhythmicity (Table III) . At no time after indomethacin was the amniotic fluid pressure higher than the lowest pressure recorded before indomethacin. We chose 30 min because that is the time we measured the eff'ects of indomethacin on uteroplacental hemodynamics and prostaglandin synthesis. It thus appears that indomethacin in late pregnancy decreases uterine tone as measured by intraamniotic fluid pressure.
DISCUSSION
The importance of uteroplacental prostaglandin production during pregnancy is unclear. Initial animal studies and later clinical studies showed that inhibition of' prostaglandin synthesis in late pregnancy is not associated with fetal death in utero (2, 3, 11, 22) but may result in premature closure of the ductus arteriosus (23) (24) (25) (26) . The role of prostaglandins in labor is more clear-cut. Not only do indomethacin and other nonsteroidal anti-inflammatory drugs inhibit the onset of labor (1, (27) (28) (29) , but large surges of PGF2,,O and its metabolite have been measured in the blood at the initiation of labor (21) . PGF, levels before labor, even in late pregnancy, are very low, whereas the concentrations of PGE2 in human amniotic fluid, in rabbit uterine vein, and dog uterine vein have all been reported to be high during the latter stages of' pregnancy (30, 31, 4) . Therefore, it appears that, of the prostaglandins studied, PGE2 is being produced by the uteroplacental Unlit in measurable quantities in late pregnancy, whereas PGF2ot production is related to the onset of labor. Our data are in agreement with the literature in this regard.
The exact site of' PGE2 production in the f'eto-placental unit is not known. PGE2 is very potent in producing contraction of the pregnant uterus (32) . If' PGE, is either produced in the myometrium or comes in conitact with the myometrium, it is quite likely that PGE., would contribute to the myometrial tone in late pregnancy. Our intraamniotic fluid pressure data in dogs would support this concept. The f'act that myometrial tone is a determinant of placental blood flow has been studied by several investigators. Novy foiuld that myometrial contraction produced by exogenously adminiistered PGE2 is associated with a large drop in placenital blood flow in pregnant monkeys (9) . In f'act, he was able to establish an inverse linear relationship between uterine blood flow and intraamniotic fluid pressture. Also, angiographic studies in pregnanit womein ani( monkeys have shown that blood flow to the placenta is markedly suppressed during uterine contraction (33, 34) . Blood flow to the placenta is not constant as in organs with capillary beds but occulrs in spurts throUgh the spiral arteries, and these spturts decrease or (lisappear dcuring contraction of the pregnant uiteruis. A recent report by Rankin and Phernetton (19) also showed that PGE2 infused into the ovine mlaternial arterial system cauises myometrial contraction and a decrease in titerine blood flow7. However, inftision of PGE2 into the fettus cauised a minimal increase in Imcaternal uiterine and renal blood flowr. Becauise the platcenta is rich in the degradative enzvme, 15-hvdroxv nificant fetal distress associated with prostaglandin synthesis inhibition.
